Japanese Major Dispensing Pharmacy Chain Ain Pharmaciez Listed On Tokyo Stock Exchange
This article was originally published in PharmAsia News
Japan's major dispensing drug store chain Ain Pharmaciez will be listed on the second section of the Tokyo Stock Exchange April 2. The Sapporo, Hokkaido-based company owns 362 dispensing pharmacies and 44 drug stores nationwide as of January. Ain achieved ¥106 billion in sales and ¥4.3 billion in profit for fiscal year 2008. Last August, the company signed a partnership agreement with Seven and I holdings to expand its healthcare business in Japan. (Click here for more - Japanese language
You may also be interested in...
US FDA investigators are more likely to cite cell and gene therapy manufacturers for facilities and production deficiencies, agency says, while industry reports difficulties complying with drug GMP requirements that are not always applicable to cell and gene therapies.
GSK’s antibody-drug conjugate may reach the market first, but CAR-T therapies from Bristol/bluebird and Janssen/Legend are close behind, and all three big pharmas have programs in earlier-stage disease.
Manufacturers warned to keep better electronic records and not falsify data in recent warning letters, ICH adds three residual solvent limits for pharmaceuticals, and the Polish authority hits firm for GMP noncompliance.